Escherichia Coli

Disease

Related News

WHO, CARB-X, and FDA Take Action on Antibiotic Resistance Crisis

The World Health Organization published blueprints for urgently needed antibiotics targeting drug-resistant infections, while CARB-X awarded $1.2 million for novel antibiotic research and the FDA issued guidance on antibiotic duration limits in livestock.

Related Clinical Trials

NCT ID Title Status Phase
NCT06858046

Health Impacts of Street Vended Fruits

COMPLETED NA
NCT06559618

Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

RECRUITING PHASE1
NCT05880069

Clinical Outcomes in Patients With Infection by Resistant Microorganism

UNKNOWN
NCT02367339

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

UNKNOWN